UK government

Downing Street, London, UK
#Funding #Life sciences #Research and development #UK #UK government

UK government commits £13.9 billion for R&D funding

The UK Department for Science, Innovation and Technology (DSIT) has set out how it will allocate £13.9 ($17.9) billion in funding for transformational research and development in the next year in areas like life sciences, green energy, engineering and beyond.   UK Research and Innovation (UKRI) – the… Read More

#News #Trending News

Great British Pounds, Investment
#Association of the British Pharmaceutical Industry #Pharmaceutical industry #UK #UK government

ABPI criticises “excessive” payment rates on branded medicines

The Association of the British Pharmaceutical Industry (ABPI) has warned that “rocketing payment rates are undermining the UK government’s efforts to make life sciences a key pillar of its industrial strategy”.  The government is proposing to raise the Statutory Scheme payment rate for newer branded medicines from… Read More

#News

#Epigenetics #Genetics / genomics #Oxford Nanopore Technologies #UK Biobank #UK government

UK partners to create world’s largest epigenetic dataset

A world-first ‘epigenetic map’ of the human genome could lead to breakthroughs in new diagnoses and treatments, say UK scientists.  This new resource for medical researchers will be created though a new strategic partnership between the UK government, Oxford Nanopore Technologies, UK Biobank, NHS England and Genomics… Read More

#News #Trending News

Downing Street, London, UK
#ABPI #Association of the British Pharmaceutical Industry #Life sciences #NHS #The King's Fund #UK government

Strong leadership needed for UK life sciences industry success

Health and care researchers at The King’s Fund are calling for the UK government and national NHS leaders to play a greater role in developing guidance and providing leadership of health service partnerships with the life sciences industry.   The UK has a large and thriving life… Read More

#News

#Finance #Funding #Investment #Politics #Private investment #UK government

New DDW Highlights episode: 4 November 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week that saw a second monoclonal antibody rejected by UK… Read More

#News

#Finance #Funding #Investment #Politics #Private investment #UK government

This week in drug discovery (28 Oct – 1 Nov) 

News round-up for 28 Oct – 1 Nov by DDW Senior Digital Content Editor Diana Spencer. In a week that saw a second monoclonal antibody rejected by UK regulator NICE, antibodies have been high on the news agenda. More positively, a new indication for Fasenra was approved in… Read More

#News

Great British Pounds, Investment
#ABPI #Life sciences #UK budget #UK economy #UK government

UK Chancellor backs life sciences in the Budget

The UK’s Labour Government has announced its first budget, which focuses on stability, investment, and long-term growth. Key announcements in the Budget included increases in NHS funding, a £520m life sciences innovative manufacturing fund, and investment in research and development, including increased funding for the National… Read More

#News #Trending News

#Finance #Funding #Investment #Politics #Private investment #UK government

New DDW Highlights episode: 29 October 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With a presidential election just round the corner in the US and… Read More

#News

#Finance #Funding #Investment #Politics #Private investment #UK government

This week in drug discovery (21-25 October) 

News round-up for 21-25 October by DDW Senior Digital Content Editor Diana Spencer. With a presidential election just round the corner in the US and a new UK budget on the way, financial support for life sciences is high on the agenda, so the news round-up this week… Read More

#News

#Association of the British Pharmaceutical Industry #Life sciences #UK budget #UK economy #UK government

Calls for life sciences and new medicines support in UK Budget

With a new UK Budget looming on 30 October, the first of this new Labour government, the Chancellor has been urged to protect the country’s life sciences sector and increase investment in medicines. Concerns have been raised in response to rumours of potential cuts to UK… Read More

#News

UK visa application
#Cancer Research UK #Life sciences #Politics #UK #UK government

Strict UK immigration rules hold back cancer research

The UK immigration system is making it much harder for the country’s research institutions to compete for international talent, says Cancer Research UK (CRUK). With their annual visa costs projected to rise by 44% in a single year, the organisation is calling on the new UK… Read More

#News #Trending News

Voting at the ballot box
#India #Life sciences #Market reporting #Politics #UK government #United States

The politics of health: How 2024 elections will impact life sciences

With elections this year in the US, the UK and India – all major players in the life sciences industry – Ivor Campbell, Chief Executive, Snedden Campbell, asks what changes and benefits we can expect to see for companies and their investors, healthcare providers and patients. The global landscape for… Read More

#Exclusive Content #Trends & Analysis

Downing Street, London, UK
#Life sciences #Opinion #Pharmaceuticals #Regulatory #UK government

What the UK’s change of government means for global life science

On Friday 5 July, the United Kingdom saw a change in government to the Labour Party after 14 years of Conservative Party leadership. DDW’s Megan Thomas explores how this political change will influence the global life science sector.  Economic power in the life sciences ecosystem  According to the National Institute… Read More

#Exclusive Content #Opinion #Regulatory

Polling station sign
#Association of the British Pharmaceutical Industry #Drug discovery #Medicines Discovery Catapult #UK #UK government

UK 2024 election: A vote for drug discovery

By DDW Editor Reece Armstrong The upcoming general election in the UK has placed the priorities of the country into the spotlight and the drug discovery sector should in no way be forgotten. Economic uncertainty, challenging global conditions and a healthcare system facing serious pressures, means that whatever government takes the… Read More

#Exclusive Content #Opinion

UK Department of Education
#Advanced Therapies #Cell and gene therapy #Cell and Gene Therapy Catapult #UK government

UK’s Education Secretary joins CGT Catapult to celebrate apprentices 

The UK’s Education Secretary Gillian Keegan attended a meeting with the Cell and Gene Therapy Catapult (CGT Catapult) to discuss the role of apprenticeships in the advanced therapies industry.  The meeting, which took place at Teesside University’s National Horizons Centre in Darlington during National Apprenticeship Week, highlighted how apprenticeships are… Read More

#News #Regulatory

Downing Street, London, UK
#Association of the British Pharmaceutical Industry #Investment #Life sciences #UK government

The ABPI sets out a manifesto for UK life sciences

The Association of the British Pharmaceutical Industry (ABPI) has published a manifesto outlining what a UK government must do to make the country a great place to research and develop the medicines and vaccines of the future. The ABPI manifesto for investment, health and growth sets out a vision for… Read More

#Business & Investment #News